Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17 | 0 | 0 | 6 | 33 |
| Other current assets | 0 | 49 | 49 | 49 | 49 |
| TOTAL | $45 | $107 | $150 | $145 | $121 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 3 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $3 |
| Total Assets | $45 | $107 | $150 | $145 | $124 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,772 | 3,729 | 3,559 | 3,442 | 3,303 |
| Accrued Expenses | 2,084 | 1,890 | 1,695 | 1,500 | 1,304 |
| TOTAL | $7,490 | $7,146 | $6,767 | $6,373 | $5,857 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,490 | $7,146 | $6,767 | $6,373 | $5,857 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,369 | 405 | 387 | 387 | 387 |
| Common Shares | 0 | 4 | 4 | 4 | 4 |
| Retained earnings | -166,509 | -165,881 | -165,412 | -164,934 | -164,394 |
| Other shareholders' equity | 22 | 22 | 22 | 22 | 22 |
| TOTAL | $-7,445 | $-7,039 | $-6,617 | $-6,228 | $-5,733 |
| Total Liabilities And Equity | $45 | $107 | $150 | $145 | $124 |